BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2014
View Archived Issues
VU-0453595 shows potential for schizophrenia in a mouse model
Read More
Preliminary data on safety and efficacy of ALD-403 for the prevention of migraine
Read More
Protagen and Qiagen to develop protein-based companion diagnostics for autoimmune drugs
Read More
Maruho announces results of the phase III study of M-8010 for the treatment of psoriasis vulgaris
Read More
Theravectys updates on phase I/II trial of lentiviral vector HIV vaccine
Read More
Intellia Therapeutics closes financing to develop ex vivo gene therapies using CRISPR-Cas9 system
Read More
Preclinical data for an orally active opioid analgesic, SEO-16
Read More
Clinical benefit on rheumatoid arthritis demonstrated in phase I trial of FPA-008
Read More
Preliminary results of a phase II study comparing AQ-13 to coartemether
Read More
CYP7A1 inhibitor NGM-282: results of first phase I trial
Read More
Aldoxorubicin clinical trials placed on partial clinical hold
Read More
Spinal muscular atrophy program enters phase Ib/IIa trial
Read More
Health Canada clears Immunovaccine to conduct phase II trial of DPX-Survivac
Read More
Kissei Pharmaceutical submits NDA in Japan for PA-21
Read More
FDA grants orphan drug designation to Cabaletta for SCA3
Read More
Merrimack Pharmaceuticals receives FDA fast track designation for MM-398
Read More
Synergy Pharmaceuticals reports data from phase II SP-333 trial
Read More
Ajinomoto discloses new GS activators for diabetes
Read More
Merck & Co. patents novel MAPK 1 inhibitors for cancer
Read More
Vitae Pharmaceuticals patent reports new RORgamma inverse agonists
Read More
Janssen files NDA for 3-month formulation of paliperidone palmitate for schizophrenia
Read More
New compounds for bacterial infections designed by Neoculi
Read More
BerGenBio's BGB-324 receives FDA orphan drug designation
Read More
FDA awards breakthrough therapy designation to dupilumab for atopic dermatitis
Read More
Janssen files MAA for Simponi in severe active non-radiographic axial spondyloarthritis
Read More